U.S. patent application number 11/981831 was filed with the patent office on 2008-07-31 for device and method for manipulating minute ventilation.
Invention is credited to David Ligon, Amir J. Tehrani.
Application Number | 20080183240 11/981831 |
Document ID | / |
Family ID | 34465515 |
Filed Date | 2008-07-31 |
United States Patent
Application |
20080183240 |
Kind Code |
A1 |
Tehrani; Amir J. ; et
al. |
July 31, 2008 |
Device and method for manipulating minute ventilation
Abstract
A stimulation device is provided that stimulates breathing to
manipulate blood gas concentrations such as SaO.sub.2 or PCO.sub.2
and thereby treat underlying causes of breathing disorders and
heart failure progression. A programmable device is provided for
setting diaphragm stimulation waveforms that adjust minute
ventilation about a predetermined baseline value. Normal breathing
of the subject is observed to establish a baseline reference minute
ventilation, and the device is programmed to produce stimulation
waveforms that may provide either a decrease or an increase in the
patients minute ventilation. The minute ventilation of the subject
may be decreased or increased from the baseline level by decreasing
or increasing a parameter that changes minute ventilators.
Inventors: |
Tehrani; Amir J.; (San
Francisco, CA) ; Ligon; David; (San Francisco,
CA) |
Correspondence
Address: |
RMX, L.L.C.
P.O. Box 3550 Loyola Corners Station
Los Altos
CA
94024
US
|
Family ID: |
34465515 |
Appl. No.: |
11/981831 |
Filed: |
October 31, 2007 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10966472 |
Oct 15, 2004 |
|
|
|
11981831 |
|
|
|
|
10686891 |
Oct 15, 2003 |
|
|
|
10966472 |
|
|
|
|
Current U.S.
Class: |
607/42 |
Current CPC
Class: |
A61B 5/4818 20130101;
A61B 5/7264 20130101; A61B 5/389 20210101; A61N 1/36132 20130101;
A61B 5/08 20130101; A61N 1/3601 20130101 |
Class at
Publication: |
607/42 |
International
Class: |
A61N 1/36 20060101
A61N001/36 |
Claims
1-25. (canceled)
26. A method of treating a cardiovascular disorder comprising:
stimulating tissue to elicit a diaphragm response to manipulate
blood gas levels to thereby reduce a load on the heart.
27. The method of 26 wherein the stimulation is configured to
elicit a diaphragm response to thereby increase SAO2 levels for a
predetermined period of time.
28. The method of claim 27 wherein the stimulation is provided
periodically wherein the heart is remodeled.
29. A method for treating a subject having a disorder characterized
by a lower resting lung volume comprising: stimulating tissue to
elicit a diaphragm response to thereby increase volume during a
non-inspiratory phase.
30. The method of claim 29 wherein the step of stimulating tissue
comprises: stimulating tissue to improve gas exchange.
31. The method of claim 29 wherein the step of stimulating
comprises stimulating with an exhalation bias waveform.
32. A diaphragm stimulation device for use with a ventilator:
wherein the device is configured to stimulate tissue of a subject
to elicit a diaphragm response; wherein the device comprises a
sensor configured to sense diaphragm EMG and a device configured to
sense diaphragm movement; and wherein the device is configured to
turn off diaphragm stimulation when diaphragm movement is sensed in
the absence of sensing a diaphragm EMG.
33. A system for diaphragm stimulation to elicit a minute
ventilation different from the normal respiratory minute
ventilation, comprising: a programmable stimulation device for
stimulating tissue of a subject to thereby elicit diaphragm
response; a sensor configured to sense a respiration parameter
corresponding to a normal minute ventilation; wherein said
programmable stimulation device is programmable to provide a
stimulation waveform to said diaphragm to elicit a minute
ventilation different from the normal respiratory minute
ventilation.
34. The system of claim 33, wherein said sensor is configured to
sense a parameter corresponding to tidal volume.
35. The system of claim 33, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to respiratory tidal volume that is less than
said normal tidal volume.
36. The system of claim 33, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to respiratory tidal volume that is greater
than said normal tidal volume.
37. The system of claim 33, wherein said sensor is configured to
sense a respiration parameter corresponding to a normal inspiration
duration
38. The system of claim 33, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to a normal inspiration duration associated
with a normal respiratory rate.
39. The system of claim 33, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to an inspiration duration associated with a
decreased respiratory rate.
40. The system of claim 33, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to an inspiration duration associated with an
increased respiratory rate.
41. A method for providing a decreased minute ventilation in a
subject with a programmable stimulation device coupled to tissue,
said method comprising: observing a normal tidal volume and a
normal respiratory rate of said subject; determining stimulation
waveform parameters for producing a normal respiratory rate and a
decreased tidal volume in said subject; storing said stimulation
waveform parameters in said programmable device; and applying a
waveform stimulus to said tissue to elicit a diaphragm response
wherein said waveform stimulus is characterized by said stimulation
waveform parameters.
42. A method for providing an increased minute ventilation in a
subject with a programmable stimulation device coupled to tissue of
the subject, said method comprising: observing a normal tidal
volume and a normal respiratory rate of said subject; determining
stimulation waveform parameters for producing a normal respiratory
rate and an increased tidal volume in said subject; storing said
stimulation waveform parameters in said programmable device; and
applying a waveform stimulus to said tissue to elicit a diaphragm
response wherein said waveform stimulus is characterized by said
stimulation waveform parameters.
43. A method of respiration therapy comprising: increasing minute
ventilation with respect to a baseline minute ventilation by
providing stimulation to elicit a diaphragm activation to increase
one or more of a respiration rate, an inspiration duration, and a
ratio of inspiration duration with respect to a corresponding
respiration cycle duration.
44. A method for providing a decreased minute ventilation in a
subject with a programmable stimulation device coupled to a tissue
of the subject, said method comprising: observing a normal tidal
volume and a normal respiratory rate of said subject; determining
stimulation waveform parameters for producing a decreased
respiratory rate and a normal tidal volume in said subject; storing
said stimulation waveform parameters in said programmable device;
and applying a waveform stimulus to said tissue to elicit a
diaphragm response, wherein said waveform stimulus is characterized
by said stimulation waveform parameters.
45. A method for establishing a baseline minute ventilation for a
subject with an implanted programmable diaphragm stimulation
device, said method comprising: attaching a flow sensor to said
subject; observing a normal tidal volume and a normal respiratory
rate; measuring and storing data concerning the respiration of said
subject; and determining a normal inspiration duration.
46. The method of claim 45, wherein said observing a normal tidal
volume and normal respiratory rate of said subject comprises
interacting with said subject while said subject is in a waking
state.
47. The method of claim 45, wherein said observing a normal tidal
volume and normal respiratory rate of said subject comprises
observing said subject while said subject is in a sleeping
state.
48. The method of claim 45, further comprising collecting
respiratory gas composition data.
49. The method of claim 45, wherein said determining a normal
inspiration duration comprises calculating an average.
50. The method of claim 45, further comprising collecting blood gas
composition data.
51. A respiration stimulation device to change minute ventilation
with respect to a baseline minute ventilation comprising: at least
one electrode configured to be coupled to tissue of a subject; a
signal source coupled to the electrode and configured to deliver a
stimulation signal to the tissue to control breathing; wherein the
signal source is configured to control at least one parameter
corresponding to minute ventilation to change minute ventilation
with respect to a baseline minute ventilation.
52. The device of claim 51 wherein the signal source is configured
to increase minute ventilation with respect to the baseline minute
ventilation.
53. The device of claim 51, wherein the signal source is configured
to decrease minute ventilation with respect to the baseline minute
ventilation.
54. A system for diaphragm stimulation to elicit a tidal volume
different from a normal respiratory tidal volume, comprising: a
programmable stimulation device for stimulating tissue of a subject
to thereby elicit diaphragm response; a sensor configured to sense
a respiration parameter corresponding to a normal tidal volume;
wherein said programmable stimulation device is programmable to
provide a stimulation waveform to said diaphragm to elicit a tidal
volume different from a normal respiratory tidal volume sensed by
said sensor.
55. The system of claim 54, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to respiratory tidal volume that is less than
said normal tidal volume.
56. The system of claim 54, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to respiratory tidal volume that is greater
than said normal tidal volume.
57. The system of claim 54, wherein said sensor comprises a flow
sensor configured to be coupled to a programmer.
58. The system of claim 54, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to a normal inspiration duration associated
with a normal respiratory rate.
59. The system of claim 54, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to an inspiration duration associated with a
decreased respiratory rate.
60. The system of claim 54, wherein said programmable stimulation
device is programmable to provide a stimulation waveform to said
tissue corresponding to an inspiration duration associated with an
increased respiratory rate.
61. A method of providing respiratory therapy comprising: providing
an electrical stimulator configured to stimulate tissue to activate
a portion of a diaphragm comprising: stimulating tissue during
exhalation to activate at least a portion of a diaphragm in a
manner that increases end expiratory lung volume.
62. A method for treating a subject with a breathing disorder
comprising the step of: electrically stimulating tissue of a
patient to elicit a diaphragm response, wherein the step of
electrically stimulating tissue comprises: electrically stimulating
tissue of the subject during a non-inspiratory phase of a
respiration cycle.
63. The method of treating a patient of claim 62 wherein the step
of treating a patient comprises treating a patient having a disease
state characterized at least in part by a gas exchange problem seen
in the disease state at a lower resting lung volume.
64. The method of treating a patient of claim 62 wherein the step
of treating a patient with a breathing disorder comprises treating
a patient with apnea.
65. The method of treating a patient of claim 62 wherein the step
of treating a patient with a breathing disorder comprises treating
a patient with an obstructive breathing disorder.
66. The method of treating a patient of claim 62 wherein the step
of treating a patient with a breathing disorder comprises treating
a patient with hyperventilation.
67. The method of treating a patient of claim 62 wherein the step
of treating a patient with a breathing disorder comprises treating
a patient with hypoventilation.
68. The method of treating a patient of claim 62 wherein the step
of treating a patient with a breathing disorder comprises treating
a patient with partial apnea.
Description
RELATED APPLICATION DATA
[0001] This application is related to U.S. patent application Ser.
No. 10/686,891, "BREATHING DISORDER DETECTION AND THERAPY DELIVERY
DEVICE AND METHOD", by Tehrani et al., filed Oct. 15, 2003, and
incorporated herein by reference.
FIELD OF THE INVENTION
[0002] The present invention relates to devices, systems, and
methods useful for providing ventilation through stimulation of the
diaphragm.
BACKGROUND OF THE INVENTION
[0003] The human body's ability to maintain homeostasis is due in
part due to respiratory functions controlled by the brain and
associated feedback systems. In maintaining homeostasis,
respiratory functions typically alter both blood oxygen saturation
and carbon dioxide partial pressures.
[0004] Certain pathological conditions such as circulation delay in
heart failure patients may lead to instability in the respiratory
feedback systems. Circulatory delay is believed to cause phase
shift or time delay in the inherent blood gas sensing feedback
loop. One manifestation of this is resulting breathing disorders
including periodic breathing, Cheyne-Stokes, and apnea
(predominantly central sleep apnea (CSA)). Cheyne-Stokes
respiration is believed to occur in part because of this
circulatory delay and perceived drop in SaO.sub.2 levels. Central
apnea, and, in some cases obstructive apnea, is believed to occur
in part due to a drop in partial pressure of CO.sub.2 following a
Cheyne-Stokes hyperventilation pattern. Other conditions such as
congestive heart failure (CHF) may be able to derive a benefit by
an increase in the partial pressure of O.sub.2 above that which is
normally maintained.
[0005] Mechanical ventilators have been used to take over breathing
to ensure adequate oxygen levels in patients who cannot
sufficiently breath on their own or who stop breathing at night
during apnea events. Mechanical ventilators control the inflow and
egress of respiratory gasses by controlling combinations of flow,
pressure and/or volume. The ventilator delivers an inspiration via
positive pressure delivered into the trachea and lungs and can
control exhalation by manipulating pressure and flow.
[0006] Diaphragm stimulation has been used to create respiration in
patients who cannot breath on their own and has been suggested to
stimulate breathing when apnea occurs. Diaphragmatic stimulation
has generally been used to control inspiration via contraction of
the diaphragm muscle which creates negative intra-thoracic pressure
resulting in inspiration. Exhalation has generally been a passive
process driven by lung and thoracic compliance.
[0007] The ventilators and proposed diaphragm stimulation have not
addressed the causes of breathing disorders, but rather have been
limited to supplementing breathing when breathing is insufficient
or not present.
BRIEF SUMMARY OF THE INVENTION
[0008] The present invention provides an implantable device for
delivering electrical stimulation waveforms to the diaphragm
through one or more electrodes. In particular, one aspect of the
invention provides stimulation waveforms that are directed to
manipulation of patient blood gases, e.g., SaO.sub.2 and PCO.sub.2.
In order to achieve manipulation of blood gas concentration, in one
embodiment minute ventilation is increased or decreased with
respect to a baseline minute ventilation. This may be done by
manipulation of one or more parameters affecting minute
ventilation. Some of the parameters may include, for example, tidal
volume, respiration rate, flow morphology, flow rate, inspiration
duration, slope of the inspiration curve, and diaphragm-created or
intrathoracic pressure gradients. The implantable device may be
programmed by a programmer that is coupled to a flow sensor that
measures the natural respiration and stimulation respiration of a
subject. Normal breathing of a patient is observed to establish a
baseline reference minute ventilation, and the device is programmed
to produce stimulation waveforms that may provide either a decrease
or an increase in the patients minute ventilation.
[0009] In one embodiment of the invention the reference minute
ventilation of a patient is obtained by observing normal breathing
of a patient in an awake state, and increased and decreased minute
ventilation are obtained by interacting with the patient.
[0010] In another embodiment the reference minute ventilation of a
patient is obtained by observing the patient in the sleeping state,
and increased and decreased minute ventilation are obtained by
applying a predetermined multiplier.
[0011] In yet another embodiment the minute ventilation is
decreased from the reference level by decreasing one or more of the
following parameters: respiratory rate, inspiration duration, and
tidal volume.
[0012] In still another embodiment the minute ventilation is
increased from the reference level by increasing one or more of the
following parameters: respiratory rate, inspiration duration, and
tidal volume.
[0013] In a further embodiment an electrical stimulation waveform
is provided for creating an enhanced negative intrapleural pressure
during exhalation.
BRIEF DESCRIPTION OF THE DRAWINGS
[0014] FIG. 1 shows a diagram of a diaphragm stimulator device in
accordance with the present invention.
[0015] FIG. 2 shows a parameter table for selected respiratory
rates in accordance with the invention.
[0016] FIG. 3 shows a parameter table for measured inspiration
duration in accordance with the invention.
[0017] FIG. 4 shows a flow diagram for establishing a baseline
respiratory reference in accordance with the invention.
[0018] FIG. 5 shows a parameter table for diaphragm stimulation
parameters in accordance with the invention.
[0019] FIG. 6 shows a parameter table of the respiratory changes
associated with stimulation combinations in accordance with the
invention.
[0020] FIG. 7 shows a flow diagram for establishing stimulation
waveforms with a normal tidal volume and a normal respiratory rate
in accordance with the invention.
[0021] FIG. 8 shows a flow diagram for establishing stimulation
waveforms with a normal tidal volume and a decreased respiratory
rate in accordance with the invention.
[0022] FIG. 9 shows a flow diagram for establishing stimulation
waveforms with a normal tidal volume and an increased respiratory
rate in accordance with the invention.
[0023] FIG. 10 shows a flow diagram for establishing stimulation
waveforms with a decreased tidal volume and a normal respiratory
rate in accordance with the invention.
[0024] FIG. 11 shows a flow diagram for establishing stimulation
waveforms with a decreased tidal volume and a decreased respiratory
rate in accordance with the invention.
[0025] FIG. 12 shows a flow diagram for establishing stimulation
waveforms with a decreased tidal volume and an increased
respiratory rate in accordance with the invention.
[0026] FIG. 13 shows a flow diagram for establishing stimulation
waveforms with an increased tidal volume and a normal respiratory
rate in accordance with the invention.
[0027] FIG. 14 shows a flow diagram for establishing stimulation
waveforms with an increased tidal volume and a decreased
respiratory rate in accordance with the invention.
[0028] FIG. 15 shows a flow diagram for establishing stimulation
waveforms with an increased tidal volume and an increased
respiratory rate in accordance with the invention.
[0029] FIG. 16 shows a stimulation waveform for providing
exhalation bias in accordance with the invention.
DETAILED DESCRIPTION OF THE INVENTION
[0030] FIG. 1 shows a diagram of a system 100 for diaphragm
stimulation in accordance with the invention. A subject 105 is
implanted with a programmable stimulation device 130 that is
coupled to one or more electrodes 125 in contact with the diaphragm
120. The one or more electrodes 125 may include both sensing and
stimulation electrodes. A flow measuring device 110 (e.g., a
pneumotachometer) is used to measure the respiratory flow
characteristics (e.g., tidal volume, inspiration duration, and
respiratory rate) of the subject 105.
[0031] A programmer 140 is coupled to the flow measuring device
110. The programmer 140 is also coupled to the implanted
programmable stimulating device 130 by a telemetry wand 135. An
optional sensor 115 may also be coupled to the subject 105 and to
the programmer for collecting respiratory and/or blood gas
composition data (e.g., pulse oximetry or exhaled gas
composition).
[0032] The system 100 may be used to determine a minute ventilation
baseline reference value for a subject and the device 130 may be
programmed to provide a waveform stimulus to adjust the minute
ventilation of the subject about the baseline reference value.
Minute ventilation is the tidal volume.times.respiration rate for a
minute of time. Minute ventilation may be determined by an ensuing
tidal volume over time or an instantaneous value. The minute
ventilation of the subject generally increases or decreases with
increase or decrease in energy (e.g., in frequency, current, pulse
width, or amplitude) applied to the diaphragm. The energy applied
by the device 130 may be adjusted by selection of the amplitude,
frequency, pulse width, and duration of the series of pulses or
stimulus waveform applied by the device 130.
[0033] The device may be programmed to produce stimulation
waveforms that vary the combination of respiratory rate and tidal
volume which result in an increase or decrease of minute
ventilation from a reference level. Increasing minute ventilation
generally increases the partial pressure of O.sub.2 compared to a
reference minute ventilation. Decreasing minute ventilation
generally increases the partial pressure of CO.sub.2 compared to a
reference minute ventilation. Accordingly, the invention provides a
method and device that manipulates blood gas concentration.
[0034] The system shown in diagram 100 may be used to observe the
natural normal, or intrinsic respiration of a subject in either the
waking state or the sleeping state. When the flow measuring device
110 is a pneumotachometer, the subject will more likely be in the
waking state.
[0035] The device 130 may be programmed to provide stimulation
assistance that is correlated with normal respiration rate
(RR.sub.n), decreased respiration rate (RR.sub.d), or increased
respiration rate (RR.sub.i). FIG. 2 shows a parameter table for
selecting respiratory rates in accordance with an embodiment of the
present invention. The value for RR.sub.d is selected as a fixed
percentage (100-X) of the observed normal respiratory rate of the
subject. Similarly, The value for RR.sub.i is selected as a fixed
percentage (100+Y) of the observed normal respiratory rate of the
subject. Although X and Y are not required to be equal, for
simplicity they are set equal in the discussion that follows.
[0036] FIG. 3 shows a parameter table for measured inspiration
duration in accordance with an embodiment of the present invention.
Typically, inspiration duration is not constant and will vary
inversely with the respiration rate. Thus, a decreased inspiration
duration ID.sub.d is associated with an increased respiratory rate
RR.sub.d, and an increased inspiration duration ID.sub.i is
associated with a decreased respiratory rate RR.sub.d. In order to
establish the duration of the stimulus waveform for a constant
tidal volume, the subject's inspiration duration is measured while
breathing at the selected breathing rates. In this example, the
target tidal volume is the same as the observed normal tidal volume
value.
[0037] For stimulation therapy that is to be delivered while a
patient is sleeping, the most accurate baseline respiratory rate
and tidal volume are those that are observed while the subject is
asleep. However, since monitoring of a sleeping subject may not
provide the required respiratory rates at the normal tidal volume,
a waking subject may be coached to provide the required tidal
volume and respiratory rate combinations so that the associated
inspiration duration can be measured. A clinician will typically
allow a period of time for the subject to be relaxed.
Alternatively, hypnosis or meditative techniques may used to place
the subject in a suitable state. In order to obtain defined
parameter values an average over two or more inspiration/exhalation
cycles may be taken.
[0038] FIG. 4 shows a flow diagram for establishing a baseline
respiratory reference for a subject in accordance with a method
embodiment of the present invention. In step 405 a flow sensor
(e.g., a pneumotachometer) is attached to the subject. In step 410
the normal tidal volume and normal respiration rate are observed.
In step 415, when the subject is in a satisfactory state, the
electromyogram (EMG) of the diaphragm, tidal volume, and
inspiration duration are measured and recorded. In step 420 the
normal inspiration duration ID.sub.n is determined. The value for
ID.sub.n may be an average of selected observed values (e.g., a
moving average).
[0039] In step 425 a decreased respiration rate at the normal tidal
volume is observed. In step 430 the electromyogram (EMG) of the
diaphragm, tidal volume, and inspiration duration are measured and
recorded. The subject may be breathing spontaneously or may be
coached. In step 435 the decreased inspiration duration ID.sub.d is
determined. The value for ID.sub.d may be an average of selected
observed values (e.g., a moving average).
[0040] In step 440 an increased respiration rate at the normal
tidal volume is observed. In step 445 the electromyogram (EMG) of
the diaphragm, tidal volume, and inspiration duration are measured
and recorded. The subject may be breathing spontaneously or may be
coached. In step 450 the increased inspiration duration ID.sub.i is
determined. The value for ID.sub.i may be an average of selected
observed values (e.g., a moving average). At step 455 the baseline
reference determination is complete. While the ID.sub.d and
ID.sub.i may be measured as noted, they also may be calculated
based on the ID.sub.n, for example, as a percentage change from the
ID.sub.n.
[0041] FIG. 5 shows a parameter selection table for diaphragm
stimulation parameters in accordance with an embodiment of the
present invention. Diaphragm stimulation may be used to adjust
minute ventilation by varying the tidal volume and/or respiratory
rate. The preferred range for the change in tidal volume from
normal is 10-30% of normal and the preferred range for the change
in respiratory rate from normal is 30-50%.
[0042] When applying stimulus waveforms between cycles in a
subject's spontaneous breathing pattern, the inspiration duration
must be correlated with the subject's respiratory rate. Thus,
although the tidal volume may be adjusted through adjustments in
inspiration duration, it is preferable to adjust the tidal volume
by adjusting the frequency and amplitude of the stimulus
waveform.
[0043] FIG. 6 shows a parameter table of the minute ventilation
changes associated with stimulation combinations in accordance with
an embodiment of the present invention. The table in FIG. 6 is a
3.times.3 matrix of minute ventilation that is the product of
respiratory rate (at a given inspiration duration) and tidal
volume. The up and down arrows in the matrix of the table in FIG. 6
correspond to a respective increase or decrease in minute
ventilation in relation to the minute ventilation for normal tidal
volume and RR.sub.n/ID.sub.n. For example, the combination of
RR.sub.d/ID.sub.d and decreased tidal volume result in a decrease
in minute ventilation, and the combination of RR.sub.i/ID.sub.i and
increased tidal volume produce an increase in minute ventilation.
These results are consistent regardless of the percent change
selected for tidal volume and respiratory rate within the preferred
ranges shown in FIG. 5.
[0044] It should be noted that the combination of RR.sub.i/ID.sub.i
and decreased tidal volume may produce either an increase or
decrease in minute ventilation, depending upon the values selected
for percent change in tidal volume and respiratory rate. The
discrete values in the table of FIG. 6 may be used to provide
limits for continuously variable parameters. Continuous parameter
functions may be obtained by interpolation of discrete values.
[0045] FIG. 7 shows a flow diagram for establishing stimulation
waveforms with a normal tidal volume and a normal respiratory rate
in accordance with a method embodiment of the present invention. In
step 705 the observed normal tidal value is selected as a target.
In step 710 the waveform inspiration duration is set to the
ID.sub.n associated with the normal respiratory rate.
[0046] In step 715 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp value variations (i.e., increases in amplitude and/or
frequency during a stimulation burst or series of pulses. These
values are selected to produce the observed normal tidal volume.
The values may be selected on the basis of information specific to
the subject such as previously observed mapping data. A discussion
of diaphragm mapping and stimulus waveforms may be found in
application Ser. No. 10/686,891, "BREATHING DISORDER DETECTION AND
THERAPY DELIVERY DEVICE AND METHOD", by Tehrani et al., filed Oct.
15, 2003, and incorporated herein by reference, and in related U.S.
patent application entitled "SYSTEM AND METHOD FOR MAPPING
DIAPHRAGM ELECTRODE SITES" filed on even date herewith.
[0047] In step 720 the stimulation waveform is delivered to the
diaphragm. In step 725 the response to the stimulation waveform is
measured. In step 730 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 705. If the criterion is not met step 735 is executed. In step
735 the stimulation waveform is adjusted. If the criterion is met
in step 730, step 740 is executed. In step 740 the waveform
parameters are stored for normal tidal volume at normal respiratory
rate. In step 745 the stimulation waveform parameters are
established.
[0048] FIG. 8 shows a flow diagram for establishing stimulation
waveforms with a normal tidal volume and a decreased respiratory
rate in accordance with a method embodiment of the present
invention. In step 805 the observed normal tidal value is selected
as a target. In step 810 the waveform inspiration duration is set
to the ID.sub.d associated with the decreased respiratory rate for
example, as determined herein with reference to FIG. 2 or 3.
[0049] In step 815 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the observed
normal tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0050] In step 820 the stimulation waveform is delivered to the
diaphragm. In step 825 the response to the stimulation waveform is
measured. In step 830 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 805. If the criterion is not met step 835 is executed. In step
835 the stimulation waveform is adjusted. If the criterion is met
in step 830, step 840 is executed. In step 840 the waveform
parameters are stored for normal tidal volume at decreased
respiratory rate. In step 845 the stimulation waveform parameters
are established.
[0051] FIG. 9 shows a flow diagram for establishing stimulation
waveforms with a normal tidal volume and an increased respiratory
rate in accordance with a method embodiment of the present
invention. In step 905 the observed normal tidal value is selected
as a target. In step 910 the waveform inspiration duration is set
to the ID.sub.i associated with the increased respiratory rate.
[0052] In step 915 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the observed
normal tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0053] In step 920 the stimulation waveform is delivered to the
diaphragm. In step 925 the response to the stimulation waveform is
measured. In step 930 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 905. If the criterion is not met step 935 is executed. In step
935 the stimulation waveform is adjusted. If the criterion is met
in step 930, step 940 is executed. In step 940 the waveform
parameters are stored for normal tidal volume at increased
respiratory rate. In step 945 the stimulation waveform parameters
are established.
[0054] FIG. 10 shows a flow diagram for establishing stimulation
waveforms with a decreased tidal volume and a normal respiratory
rate in accordance with a method embodiment of the present
invention. In step 1005 the observed decreased tidal value is
selected as a target. In step 1010 the waveform inspiration
duration is set to the ID.sub.n associated with the normal
respiratory rate.
[0055] In step 1015 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the selected
decreased tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0056] In step 1020 the stimulation waveform is delivered to the
diaphragm. In step 1025 the response to the stimulation waveform is
measured. In step 1030 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 1005. If the criterion is not met step 1035 is executed. In
step 1035 the stimulation waveform is adjusted. If the criterion is
met in step 1030, step 1040 is executed. In step 1040 the waveform
parameters are stored for decreased tidal volume at normal
respiratory rate. In step 1045 the stimulation waveform parameters
are established.
[0057] FIG. 11 shows a flow diagram for establishing stimulation
waveforms with a decreased tidal volume and a decreased respiratory
rate in accordance with a method embodiment of the present
invention. In step 1105 the observed decreased tidal value is
selected as a target. In step 1110 the waveform inspiration
duration is set to the ID.sub.d associated with the decreased
respiratory rate.
[0058] In step 1115 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the selected
decreased tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0059] In step 1120 the stimulation waveform is delivered to the
diaphragm. In step 1125 the response to the stimulation waveform is
measured. In step 1130 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 1105. If the criterion is not met step 1135 is executed. In
step 1135 the stimulation waveform is adjusted. If the criterion is
met in step 1130, step 1140 is executed. In step 1140 the waveform
parameters are stored for decreased tidal volume at decreased
respiratory rate. In step 1145 the stimulation waveform parameters
are established.
[0060] FIG. 12 shows a flow diagram for establishing stimulation
waveforms with a decreased tidal volume and an increased
respiratory rate in accordance with a method embodiment of the
present invention. In step 1205 the observed decreased tidal value
is selected as a target. In step 1210 the waveform inspiration
duration is set to the ID.sub.i associated with the increased
respiratory rate.
[0061] In step 1215 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the selected
decreased tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0062] In step 1220 the stimulation waveform is delivered to the
diaphragm. In step 1225 the response to the stimulation waveform is
measured. In step 1230 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 1205. If the criterion is not met step 1235 is executed. In
step 1235 the stimulation waveform is adjusted. If the criterion is
met in step 1230, step 1240 is executed. In step 1240 the waveform
parameters are stored for decreased tidal volume at increased
respiratory rate. In step 1245 the stimulation waveform parameters
are established.
[0063] FIG. 13 shows a flow diagram for establishing stimulation
waveforms with an increased tidal volume and a normal respiratory
rate in accordance with a method embodiment of the present
invention. In step 1305 the selected increased tidal value is
selected as a target. In step 1310 the waveform inspiration
duration is set to the ID.sub.n associated with the normal
respiratory rate.
[0064] In step 1315 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the selected
increased tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0065] In step 1320 the stimulation waveform is delivered to the
diaphragm. In step 1325 the response to the stimulation waveform is
measured. In step 1330 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 1305. If the criterion is not met step 1335 is executed. In
step 1335 the stimulation waveform is adjusted. If the criterion is
met in step 1330, step 1340 is executed. In step 1340 the waveform
parameters are stored for increased tidal volume at normal
respiratory rate. In step 1345 the stimulation waveform parameters
are established.
[0066] FIG. 14 shows a flow diagram for establishing stimulation
waveforms with an increased tidal volume and a decreased
respiratory rate in accordance with a method embodiment of the
present invention. In step 1405 the selected increased tidal value
is selected as a target. In step 1410 the waveform inspiration
duration is set to the ID.sub.d associated with the decreased
respiratory rate.
[0067] In step 1415 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the selected
increased tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0068] In step 1420 the stimulation waveform is delivered to the
diaphragm. In step 1425 the response to the stimulation waveform is
measured. In step 1430 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 1405. If the criterion is not met step 1435 is executed. In
step 1435 the stimulation waveform is adjusted. If the criterion is
met in step 1430, step 1440 is executed. In step 1440 the waveform
parameters are stored for increased tidal volume at decreased
respiratory rate. In step 1445 the stimulation waveform parameters
are established.
[0069] FIG. 15 shows a flow diagram for establishing stimulation
waveforms with an increased tidal volume and an increased
respiratory rate in accordance with a method embodiment of the
present invention. In step 1505 the selected increased tidal value
is selected as a target. In step 1510 the waveform inspiration
duration is set to the ID.sub.i associated with the increased
respiratory rate.
[0070] In step 1515 the stimulation waveforms are given initial
amplitude and frequency values, and initial amplitude and frequency
ramp values. These values are selected to produce the selected
increased tidal volume. The values may be selected on the basis of
information specific to the subject such as previously observed
mapping data.
[0071] In step 1520 the stimulation waveform is delivered to the
diaphragm. In step 1525 the response to the stimulation waveform is
measured. In step 1530 a criterion for accepting the response is
evaluated. For example, the measured response tidal volume must be
within a fixed percentage (e.g., 5%) of the target tidal volume of
step 1505. If the criterion is not met step 1535 is executed. In
step 1535 the stimulation waveform is adjusted. If the criterion is
met in step 1530, step 1540 is executed. In step 1540 the waveform
parameters are stored for increased tidal volume at increased
respiratory rate. In step 1545 the stimulation waveform parameters
are established.
[0072] In use the system 100 is programmed to achieve increases and
decreases in minute ventilation or other related parameters. The
system 100 is then used to manipulate PCO.sub.2 or SaO.sub.2 levels
by controlling minute ventilation or related respiration parameters
that affect minute ventilation. Blood gas levels may be manipulated
to prevent breathing disorders by stimulating the diaphragm after
detecting a precursor to a breathing disorder. Examples of such
detection and stimulation schemes are set forth in U.S. patent
application entitled "Breathing Disorder and Precursor Predictor
and Therapy Delivery Device and Method", Tehrani, et al., and
incorporated herein by reference. The stimulation waveforms may
also be used to control oxygen saturation levels to treat heart
failure patients, for example, periodically increasing oxygen
saturation levels may be therapeutic to heart failure patients by
either reducing the load on the heart and/or by having the patient
breath in a more advantageous manner. Examples of such breathing
therapies and therapy devices are described in U.S. patent
application entitled "Breathing Therapy Device and Method",
Tehrani, filed on even date herewith and incorporated in its
entirety herein by reference.
[0073] FIG. 16 shows a stimulation waveform diagram in accordance
with the invention. A stimulation waveform 1600 comprises an
inspiration stimulus 1605 and an exhalation bias waveform 1610. The
inspiration stimulus 1605 is applied for the duration that a
diaphragm stimulation has typically been applied. The exhalation
bias waveform 1610 comprises a first tapering component 1608
followed by low level biased portion 1609. The exhalation bias
waveform 1610 may be characterized by an frequency f.sub.b and an
amplitude A.sub.b.
[0074] In known diaphragm stimulation the diaphragm is allowed to
relax completely during exhalation. This relaxation typically
begins at the end of the inspiration stimulus and results in a
minimum volume being established for the lungs and airways. By
applying a low-level bias stimulus to the diaphragm during all or
part of the rest period, an enhanced negative intrapleural pressure
may be produced.
[0075] The enhanced negative pressure may used to increase the
minimum volume for the lungs and airways. In certain circumstances
it is believed that a greater minimum volume may relieve some of
the gas exchange problems seen in disease states at lower resting
lung volumes. The exhalation bias waveform 1610 provides a tool for
modifying the lung volume during exhalation phase and rest
period.
[0076] The exhalation bias waveform 1610 may be used to decrease
the tidal volume, which may be used to decrease the minute
ventilation and produce an increase in the partial pressure of
CO.sub.2.
[0077] In order to provide a smooth transition in the exhalation
phase, the exhalation waveform component 1610 containing the first
taper portion 1608 which comprises a negative ramp. The portion
1608 may be used to taper the exhalation. The low level bias
stimulus portion 1609 provides a continuous low level enhanced
negative intrapleural pressure. The portion 1609 may be applied all
or a portion of an exhalation period.
[0078] The stimulation device may be used, for example in subjects
with breathing disorders, heart failure patients and patients who
cannot otherwise breathe on their own such as spinal cord injury
patients.
[0079] Safety mechanisms may be incorporated into any stimulation
device in accordance with the invention. The safety feature
disables the device under certain conditions. Such safety features
may include a patient or provider operated switch, e.g. a magnetic
switch. In addition a safety mechanism may be included that
determines when patient intervention is being provided. For
example, the device will turn off if there is diaphragm movement
sensed without an EMG as the case would be where a ventilator is
being used.
[0080] While the invention has been described in detail with
reference to preferred embodiments thereof, it will be apparent to
one skilled in the art that various changes can be made, and
equivalents employed, without departing from the scope of the
invention.
* * * * *